<unk>  is a serotonin/norepinephrine reuptake inhibitor that is FDA approved for the treatment of fibromyalgia. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include nausea, headache, constipation, dizziness, insomnia, hot flush, hyperhidrosis, vomiting, palpitations, tachycardia, dry mouth, and hypertension.
Milnacipran hydrochloride
Cyproheptadine hydrochloride
Clebopride
Tolnaftate
Naloxegol
Pegvisomant
Dimenhydrinate
Palonosetron hydrochloride